Clinical Trial Update: Immune Activity Against CVM Retinitis

View source ↗

Summary

A completed clinical trial evaluated immune activity against Cytomegalovirus retinitis in individuals with Acquired Immunodeficiency Syndrome/HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Cytomegalovirus Retinitis
• HIV Infection

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis | Status: COMPLETED